French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...] Read More »
Category: General
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...] Read More »
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...] Read More »
GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...] Read More »
340B covered entities could soon be required to share new information—including reimbursement amounts, ship to dates and ship to locations—as [...] Read More »
A former Pfizer executive and current biopharmaceutical consultant took aim this week at what she called the “poorly managed” 340B [...] Read More »
Although Massachusetts lawmakers left Beacon Hill this month without passing a long-stalled 340B contract pharmacy access bill, provider groups say [...] Read More »
A state hospital-backed candidate won Tuesday’s Missouri Republican gubernatorial primary after defeating a high-profile opponent with dark money ties who [...] Read More »
More than two-thirds of 340B contract pharmacies are associated with pharmacy benefit managers (PBMs) through either vertical integration or contractual [...] Read More »
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...] Read More »